( en | de | ru )

 

Disambiguation of "Qu, Hongchang"

Author of the publication

copydeleteadd this publication to your clipboard
New analogs of the clinical complement inhibitor compstatin with subnanomolar affinity and enhanced pharmacokinetic properties

, , , , , , , , , , , and . Immunobiology, 218 (4): 496--505 (April 2013)
DOI: 10.1016/j.imbio.2012.06.003

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

Hong Qu

Guoqiong Qu

Jing Qu

Chengchao Qu

Lizhen Qu

 

Other publications of authors with the same name

Novel analogues of the therapeutic complement inhibitor compstatin with significantly improved affinity and potency., , , , , , , and . Molecular Immunology, 48 (4): 481--489 (January 2011)The C5a receptor impairs IL-12-dependent clearance of Porphyromonas gingivalis and is required for induction of periodontal bone loss., , , , , , , , , and . Journal of Immunology, 186 (2): 869--877 (January 2011)PMX-53 as a Dual CD88 Antagonist and an Agonist for Mas-Related Gene 2 (MrgX2) in Human Mast Cells, , , , , and . Molecular Pharmacology, 79 (6): 1005--1013 (2011)Autoregulation of thromboinflammation on biomaterial surfaces by a multicomponent therapeutic coating., , , , , , , , , and . 34 (4): 985--994 (January 2013)Protection of nonself surfaces from complement attack by factor H-binding peptides: implications for therapeutic medicine., , , , , , , , and . Journal of Immunology, 186 (7): 4269--4277 (April 2011)Complement anaphylatoxin C5a contributes to hemodialysis-associated thrombosis., , , , , , , , , and 4 other author(s). Blood, 116 (4): 631--639 (July 2010)New analogs of the clinical complement inhibitor compstatin with subnanomolar affinity and enhanced pharmacokinetic properties, , , , , , , , , and 2 other author(s). Immunobiology, 218 (4): 496--505 (April 2013)C5aR-antagonist significantly reduces the deleterious effect of a blunt chest trauma on fracture healing, , , , , , , , , and 2 other author(s). Journal of Orthopaedic Research, 30 (4): 581--586 (2012)Recent developments in low molecular weight complement inhibitors., , and . Molecular Immunology, 47 (2-3): 185--195 (December 2009)A complement receptor C5a antagonist regulates epithelial to mesenchymal transition and crystallin expression after lens cataract surgery in mice., , , , , , , , and . Molecular vision, 17 (105): 949--964 (2011)